Atlas Trials

Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events

Clinical trial NCT02939872 · COMPLETED

Trial details

NCT number
NCT02939872
Sponsor
Seung-Jung Park
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Percutaneous Transluminal Coronary AngioplastyCoronary Disease
Start date
2017-03-09
Primary completion
2021-05-09
Enrollment
238

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.